Literature DB >> 9300659

Phenotype variation and newcomers in ion channel disorders.

D E Bulman1.   

Abstract

Ion channels are part of a large family of macromolecules whose functions include the control and maintenance of electrical potential across cell membranes, secretion and signal transduction. Close inspection of the physiological processes involved in channel function and the secondary structure of various ion channels has served as a basis for subdividing ion channels into a number of superfamilies. The voltage-gated ion channels are one of these superfamilies. Recent work has shown that mutations in various ion channel genes are responsible for a number of neuromuscular and neurological disorders. Correlation of the various mutations with the clinical phenotype is providing us with insight into the pathophysiology of these channel proteins. Interestingly, different mutations within the same gene may cause quite distinct clinical disorders, while mutations in different channel genes may result in very similar phenotypes (genetic heterogeneity). Examples of phenotypic variation and genetic heterogeneity are presented in the context of the periodic paralytic disorders of skeletal muscle, episodic ataxia, migraine, long QT syndrome and paroxysmal dyskinesia. Some of these disorders are known to be caused by mutations in ion channel genes, while in the episodic movement disorders, ion channel genes are considered excellent candidate genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300659     DOI: 10.1093/hmg/6.10.1679

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation.

Authors:  S Bendahhou; T R Cummins; A F Hahn; S Langlois; S G Waxman; L J Ptácek
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans.

Authors:  S Bendahhou; T R Cummins; H Kwiecinski; S G Waxman; L J Ptácek
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

3.  Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation.

Authors:  S Bendahhou; T R Cummins; R Tawil; S G Waxman; L J Ptácek
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

4.  A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy.

Authors:  A Escayg; A Heils; B T MacDonald; K Haug; T Sander; M H Meisler
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

5.  A novel syndrome of episodic muscle weakness maps to xp22.3.

Authors:  M M Ryan; P Taylor; J A Donald; R A Ouvrier; G Morgan; G Danta; M F Buckley; K N North
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

6.  Fast- and slow-gating modes of the sodium channel are altered by a paramyotonia congenita-linked mutation.

Authors:  O Moran; R Melani; M Nizzari; F Conti
Journal:  J Bioenerg Biomembr       Date:  1998-12       Impact factor: 2.945

7.  Myopathic mutations affect differently the inactivation of the two gating modes of sodium channels.

Authors:  O Moran; M Nizzari; F Conti
Journal:  J Bioenerg Biomembr       Date:  1999-12       Impact factor: 2.945

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.